Search / Trial NCT06222138

Study of Biologic Tumor and Plasma Biomarkers of Response to TTFields in Patients Treated for Newly Diagnosed Glioblastoma

Launched by INSTITUT CLAUDIUS REGAUD · Jan 15, 2024

Trial Information

Current as of October 04, 2024

Recruiting

Keywords

Glioblastoma Biologic Tumor And Plasma Biomarkers Translational Research Tt Fields

Description

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Age ≥18 years at the time of study entry.
  • 2. Patient with newly diagnosed glioblastoma.
  • 3. Patient for which a treatment with radio-chemotherapy followed by TTFields has been decided and has not been started.
  • 4. Signed written informed consent.
  • 5. Patient able to participate and willing to give informed consent prior performance of any study-related procedures and to comply with the study protocol
  • 6. Patient affiliated to a Social Health Insurance in France.
  • Exclusion Criteria:
  • 1. Any condition contraindicated with sampling procedures required by the protocol.
  • 2. Any contraindication to the use of the medical device administering TTFields.
  • 3. Simultaneous participation in a therapeutic interventional clinical trial.
  • 4. Patient pregnant, or breast-feeding.
  • 5. Known history of positive test for hepatitis B virus or hepatitis C virus or human immunodeficiency virus (HIV) or known acquired immunodeficiency syndrome (AIDS).
  • 6. Any psychological, familial, geographic or social situation, according to the judgment of investigator, potentially preventing the provision of informed consent or compliance to study procedure
  • 7. Patient who has forfeited his/her freedom by administrative or legal award or who is under legal protection (curatorship and guardianship, protection of justice)

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

Toulouse, , France

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0